High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1

This publication has 37 references indexed in Scilit:

• Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart
  Cardiovascular Research, 2005
• Suppression of Tumor Growth and Angiogenesis in Vivo by a Truncated Form of 24-kd Fibroblast Growth Factor (FGF)-2
  The American Journal of Pathology, 2004
• New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
  Cardiovascular Research, 2004
• Augmented Expression of Cardiotrophin-1 and its Receptor Component, gp130, in both Left and Right Ventricles after Myocardial Infarction in the Rat
  Journal of Molecular and Cellular Cardiology, 2000
• Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
  Journal of Clinical Investigation, 1999
• FGF-2-induced Negative Inotropism and Cardioprotection are Inhibited by Chelerythrine: Involvement of Sarcolemmal Calcium-independent Protein Kinase C
  Journal of Molecular and Cellular Cardiology, 1998
• Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells.
  The Journal of cell biology, 1996
• Over-expression of CUG- or AUG-initiated Forms of Basic Fibroblast Growth Factor in Cardiac Myocytes Results in Similar Effects on Mitosis and Protein Synthesis but Distinct Nuclear Morphologies
  Journal of Molecular and Cellular Cardiology, 1994
• Increased Basic Fibroblast Growth Factor (bFGF) Accumulation and Distinct Patterns of Localization in Isoproterenol-Induced Cardiomyocyte Injury
  Growth Factors, 1993
• Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
  Circulation, 1978